Galderma R&D

44 marketed · 36 in Phase 3

Quick facts

Marketed products

Phase 3 pipeline

Phase 2 pipeline

Phase 1 pipeline

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

Frequently asked questions about Galderma R&D

What are Galderma R&D's marketed drugs?

Top marketed products include ABPO Forte Gel, adapalen 0.1%, Adapalene 0.1% and Benzoyl Peroxide 2.5% gel, adapalene/benzoyl peroxide, Adapalene/benzoyl peroxide gel, 0.1%/2.5%, Adapalene Gel, 0.1%.

What is Galderma R&D's pipeline?

Galderma R&D has 36 drugs in Phase 3, 18 in Phase 2, 2 in Phase 1. Late-stage candidates include Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel, Adapalene 0.3% / BPO 2.5% gel, Adapalene BPO, adapalene lotion 0.1%.

Related